Sustained Serotonergic Stimulation Platform for Peripheral Axonal Regeneration

Q3 Medicine
Sara C. Chaker BS , Ling Yan PhD , Jugal Kishore Sahoo PhD , Cengiz H. Acikel MD , Isaac V. Manzanera Esteve PhD , David L. Kaplan PhD , Michael Levin PhD , Vijay S. Gorantla MD, PhD , Wesley P. Thayer MD, PhD , Huseyin Karagoz MD, PhD
{"title":"Sustained Serotonergic Stimulation Platform for Peripheral Axonal Regeneration","authors":"Sara C. Chaker BS ,&nbsp;Ling Yan PhD ,&nbsp;Jugal Kishore Sahoo PhD ,&nbsp;Cengiz H. Acikel MD ,&nbsp;Isaac V. Manzanera Esteve PhD ,&nbsp;David L. Kaplan PhD ,&nbsp;Michael Levin PhD ,&nbsp;Vijay S. Gorantla MD, PhD ,&nbsp;Wesley P. Thayer MD, PhD ,&nbsp;Huseyin Karagoz MD, PhD","doi":"10.1016/j.jhsg.2025.100811","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Limitations remain in peripheral nerve injury treatments. Previous studies suggest that serotonergic signaling promotes nerve regeneration by facilitating reinnervation and modulating neuronal guidance. This study aimed to evaluate the potential of serotonergic peripheral neuroregeneration using Zolmitriptan, a serotonin receptor agonist.</div></div><div><h3>Methods</h3><div>A total of 24 female Sprague-Dawley rats were divided into four nerve injury cohorts. Sciatic nerve transection and primary repair were performed in two groups, whereas a 1-cm nerve defect was created and repaired with the same nerve segment as an autograft in the other two groups. One primary repair group and one nerve graft group received 1 mL of Zolmitriptan directly to the nerve via sonicated silk protein gels. Control groups received gels without Zolmitriptan. At postoperative 8 weeks, the sciatic nerves were collected for histological analysis. Ex vivo diffusion tensor magnetic resonance imaging was also used to assess axonal regeneration.</div></div><div><h3>Results</h3><div>The primary repair cohort treated with Zolmitriptan demonstrated robust regeneration, whereas the control cohort showed poorer regeneration. There was no statistical difference in regeneration between the treated and control autograft groups. When evaluating the regeneration rates of the primary repair groups, 80% of the axons successfully extended to the distal end in the Zolmitriptan group, compared with 57% in the control group. In the autograft groups, these rates were 65% for Zolmitriptan and 42% for the control. Electron microscopy supported the axonal counting results.</div></div><div><h3>Conclusions</h3><div>This pilot study suggests that Zolmitriptan may enhance peripheral nerve regeneration following transection injuries, warranting further investigation for clinical translation.</div></div><div><h3>Clinical relevance</h3><div>This study presents promising results regarding the potential of serotonin agonists to aid in peripheral nerve recovery. Additional investigation into these findings could inform new treatment strategies for peripheral nerve injuries.</div></div>","PeriodicalId":36920,"journal":{"name":"Journal of Hand Surgery Global Online","volume":"7 6","pages":"Article 100811"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hand Surgery Global Online","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589514125001318","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Limitations remain in peripheral nerve injury treatments. Previous studies suggest that serotonergic signaling promotes nerve regeneration by facilitating reinnervation and modulating neuronal guidance. This study aimed to evaluate the potential of serotonergic peripheral neuroregeneration using Zolmitriptan, a serotonin receptor agonist.

Methods

A total of 24 female Sprague-Dawley rats were divided into four nerve injury cohorts. Sciatic nerve transection and primary repair were performed in two groups, whereas a 1-cm nerve defect was created and repaired with the same nerve segment as an autograft in the other two groups. One primary repair group and one nerve graft group received 1 mL of Zolmitriptan directly to the nerve via sonicated silk protein gels. Control groups received gels without Zolmitriptan. At postoperative 8 weeks, the sciatic nerves were collected for histological analysis. Ex vivo diffusion tensor magnetic resonance imaging was also used to assess axonal regeneration.

Results

The primary repair cohort treated with Zolmitriptan demonstrated robust regeneration, whereas the control cohort showed poorer regeneration. There was no statistical difference in regeneration between the treated and control autograft groups. When evaluating the regeneration rates of the primary repair groups, 80% of the axons successfully extended to the distal end in the Zolmitriptan group, compared with 57% in the control group. In the autograft groups, these rates were 65% for Zolmitriptan and 42% for the control. Electron microscopy supported the axonal counting results.

Conclusions

This pilot study suggests that Zolmitriptan may enhance peripheral nerve regeneration following transection injuries, warranting further investigation for clinical translation.

Clinical relevance

This study presents promising results regarding the potential of serotonin agonists to aid in peripheral nerve recovery. Additional investigation into these findings could inform new treatment strategies for peripheral nerve injuries.
外周轴突再生的持续5 -羟色胺刺激平台
目的周围神经损伤的治疗仍有局限性。以往的研究表明,血清素能信号通过促进神经再生和调节神经元引导来促进神经再生。本研究旨在评估使用Zolmitriptan(一种5 -羟色胺受体激动剂)的5 -羟色胺能周围神经再生的潜力。方法将24只雌性Sprague-Dawley大鼠分为4个神经损伤组。两组进行坐骨神经横断和一期修复,而另两组则用相同的神经段修复1厘米的神经缺损。1个初次修复组和1个神经移植组分别给予1 mL佐米曲坦经声丝蛋白凝胶直接注入神经。对照组给予不含唑米曲坦的凝胶。术后8周采集坐骨神经进行组织学分析。体外扩散张量磁共振成像也用于评估轴突再生。结果经佐米曲坦治疗的初级修复组细胞再生能力较强,而对照组细胞再生能力较差。治疗组和对照组在再生方面无统计学差异。在评估初级修复组的再生率时,佐米曲坦组80%的轴突成功地延伸到远端,而对照组为57%。在自体移植物组中,佐米曲坦组的这一比例为65%,对照组为42%。电镜观察支持轴突计数结果。结论本初步研究提示佐米曲坦可促进横断损伤后周围神经的再生,值得进一步的临床应用研究。本研究提出了有关血清素激动剂帮助周围神经恢复的潜力的有希望的结果。对这些发现的进一步研究可以为周围神经损伤提供新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
111
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信